7th Apr 2010 16:08
ARK THERAPEUTICS GROUP PLC
7 April 2010
Annual Information Update
Ark Therapeutics Group plc (the "Company") is pleased to provide an annual information update in accordance with the requirements of Prospectus Rule 5.2. This update refers to information that has been published or made available by or for the Company to the public in the 12 months up to and including 31 March 2010.
The following UK regulatory announcements have been made via the Regulatory News Service provided by the London Stock Exchange:
|
Date |
Headline |
|
7 April 2009 |
Research Update |
|
7 April 2009 |
Annual Information Update |
|
22 April 2009 |
AGM Results |
|
30 April 2009 |
Prestigious European Award |
|
30 April 2009 |
Total Voting Rights |
|
5 May 2009 |
Trinam® Awarded Fast Track Status by FDA |
|
6 May 2009 |
Price Monitoring Extension |
|
6 May 2009 |
Second Price Monitoring Extension |
|
12 May 2009 |
Director/PDMR Shareholding |
|
13 May 2009 |
Price Monitoring Extension |
|
13 May 2009 |
Second Price Monitoring Extension |
|
15 May 2009 |
Cerepro® Named Patient Supply approved in Finland |
|
18 May 2009 |
Interim Management Statement |
|
21 May 2009 |
Trinam® Phase III Study Enrols First Patient |
|
3 June 2009 |
Blocklisting Interim Review |
|
17 June 2009 |
Re Agreement |
|
24 June 2009 |
Manufacturing Update |
|
26 June 2009 |
Holding(s) in Company |
|
1 July 2009 |
Re Agreement |
|
13 July 2009 |
Ark launches Kerraglove® woundcare device |
|
26 August 2009 |
Research Update |
|
26 August 2009 |
Half Yearly Report |
|
1 September 2009 |
Director/PDMR Shareholding |
|
4 September 2009 |
Research Update |
|
29 September 2009 |
Holding(s) in Company |
|
30 September 2009 |
Holding(s) in Company |
|
2 October 2009 |
Holding(s) in Company |
|
14 October 2009 |
Research Update |
|
11 November 2009 |
Interim Management Statement |
|
24 November 2009 |
Holding(s) in Company |
|
3 December 2009 |
Block Listing Interim Review |
|
3 December 2009 |
Holding(s) in Company |
|
15 December 2009 |
Holding(s) in Company |
|
18 December 2009 |
EMEA recommendation on Cerepro® |
|
22 December 2009 |
Price Monitoring Extension |
|
22 December 2009 |
Second Price Monitoring Extension |
|
5 January 2010 |
Ark files for re-examination of Cerepro® |
|
20 January 2010 |
Employee Benefit Trust |
|
28 January 2010 |
Research Update |
|
28 January 2010 |
Research Update |
|
28 January 2010 |
Notice of Results |
|
29 January 2010 |
Total Voting Rights |
|
5 February 2010 |
Price Monitoring Extension |
|
11 February 2010 |
Director/PDMR Holding |
|
16 February 2010 |
Price Monitoring Extension |
|
16 February 2010 |
Second Price Monitoring Extension |
|
19 February 2010 |
Agreement |
|
23 February 2010 |
Research Update |
|
8 March 2010 |
Holding(s) in Company |
|
9 March 2010 |
Research Update |
|
10 March 2010 |
Final Results |
|
10 March 2010 |
Piper Jaffray Ltd - EPT Disclosure |
|
10 March 2010 |
Credit Suisse Securities (Eur) Ltd - EPT Disclosure |
|
10 March 2010 |
Price Monitoring Extension |
|
10 March 2010 |
Second Price Monitoring Extension |
|
11 March 2010 |
Piper Jaffray Ltd - EPT Disclosure |
|
15 March 2010 |
Credit Suisse Securities (Eur) Ltd - EPT Disclosure |
|
15 March 2010 |
Piper Jaffray Ltd - EPT Disclosure |
|
16 March 2010 |
Piper Jaffray Ltd - EPT Disclosure |
|
16 March 2010 |
Barclays PLC Rule 8.3 |
|
16 March 2010 |
Holding(s) in Company |
|
17 March 2010 |
Credit Suisse Securities (Eur) Ltd - EPT Disclosure |
|
17 March 2010 |
Barclays PLC Rule 8.3 |
|
18 March 2010 |
Piper Jaffray Ltd - EPT Disclosure |
|
19 March 2010 |
Credit Suisse Securities (Eur) Ltd - EPT Disclosure |
|
19 March 2010 |
Piper Jaffray Ltd - EPT Disclosure |
|
19 March 2010 |
INVESCO Limited Rule 8.3 |
|
19 March 2010 |
Aviva PLC Rule 8.3 |
|
19 March 2010 |
J O Hambro Capital Management Ltd Rule 8.3 |
|
22 March 2010 |
Credit Suisse Securities (Eur) Ltd - EPT Disclosure |
|
22 March 2010 |
Piper Jaffray Ltd - EPT Disclosure |
|
22 March 2010 |
Barclays PLC Rule 8.3 |
|
22 March 2010 |
INVESCO Limited Rule 8.3 |
|
22 March 2010 |
BlackRock Group Rule 8.3 |
|
22 March 2010 |
BlackRock Group Rule 8.3 |
|
24 March 2010 |
INVESCO Limited Rule 8.3 |
|
24 March 2010 |
Credit Suisse Securities (Eur) Ltd - EPT Disclosure |
|
24 March 2010 |
Piper Jaffray Ltd - EPT Disclosure |
|
25 March 2010 |
Credit Suisse Securities (Eur) Ltd - EPT Disclosure |
|
25 March 2010 |
INVESCO Limited Rule 8.3 |
|
30 March 2010 |
INVESCO Limited Rule 8.3 |
|
30 March 2010 |
Piper Jaffray Ltd - EPT Disclosure |
|
31 March 2010 |
Credit Suisse Securities (Eur) Ltd - EPT Disclosure |
|
31 March 2010 |
Total Voting Rights |
Copies of all regulatory announcements for Ark Therapeutics Group plc can be found on the Press Release Archive page on the Company's website www.arktherapeutics.com
The Ark Therapeutics Group plc Annual Report and Accounts 2009 and the Interim Report 2009 were filed on 18 March 2010 and 26 August 2009 respectively at the UKLA Document Viewing Facility, Financial Services Authority, 25 The Colonnade, Canary Wharf, London E14 5HS. These documents are also available on the Company's website www.arktherapeutics.com or on application to the Company Secretary.
The Company has also made the following filings at Companies House:
|
Date of Filing |
Document filed |
|
17 April 2009 |
Form 88(2) Return of Allotment of Shares |
|
17 April 2009 |
Form 88(2) Return of Allotment of Shares |
|
22 April 2009 |
Resolutions passed at AGM |
|
1 July 2009 |
Form 288b Terminating Appointment as Director |
|
19 November 2009 |
Annual Return |
|
29 January 2010 |
Form SH01 - Return of allotment of shares |
|
23 March 2010 |
Annual Report and Accounts 2009 |
Copies of these documents may be obtained from Companies House, Crown Way Maindy, Cardiff CF14 3UZ or through Companies House Direct at www.direct.companieshouse.gov.uk.
Further information is available regarding the Company and its activities on its website www.arktherapeutics.com.
The information referred to in this update was up to date at the time the information was published, but some information may now be out of date.
Enquiries:
|
Ark Therapeutics Group plc Martyn Williams, Company Secretary |
020 7388 7722 |
Related Shares:
PVG.L